Compounds, compositions and methods of inhibiting alpha-synuclein toxicity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8440705
APP PUB NO 20080261953A1
SERIAL NO

11575481

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds and compositions are provided for treatment or amelioration of one or more symptoms of α-synuclein toxicity, α-synuclein mediated diseases or diseases in which α-synuclein fibrils are a symptom or cause of the disease. In one embodiment, the compounds for use in the compositions and methods are heteroaryl acylguanidines, heteroarylhydrazones, dihydropyridones, heteroaryl and aryl styryl ketones, and heteroarylpyrazoles.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • FOLDRX PHARMACEUTICALS, INC.;WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Labaudinière, Richard Sherborn, US 3 29
Lindquist, Susan L Chestnut Hill, US 34 256
Outeiro, Tiago Cambridge, US 9 80

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation